Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
life sciences
national blog main
startups
4
×
venture capital
4
×
boston
boston top stories
financing
biogen
funding
national top stories
new york blog main
new york top stories
ptc therapeutics
20/20 healthcare partners
accent therapeutics
aducanumab
akero therapeutics
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
apellis pharmaceuticals
aragon pharmaceuticals
asklepios biopharmaceutical
benzodiazepines
bioeurope
biomarin pharmaceutical
blackstone group
blackstone life sciences
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
christian angermayer
What
new
4
×
drugs
medicines
neuro
activity
aims
approach
approvals
associated
backed
bags
bio
biogen
biotechs
capital
cause
ceo
clamped
companies
covid
delays
develop
developing
device
dialysis
disease
diseases
economic
enclear
epilepsy
fast
fda
genes
genetic
harmful
including
investing
investors
ipo
isn’t
Language
unset
Current search:
new
×
startups
×
" boston blog main "
×
" venture capital "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device